BI-44847

• Description :

  BI-44847 is a selective and orally active SGLT2 inhibitor. BI-44847 can increase UGE and decrease HbA1c levels. BI-44847 shows improvement in fasting and fed glucose levels. BI-44847 can be studied in research on type 2 diabetes mellitus (T2DM) [1].

• UNSPSC :

  12352005

• Target :

  SGLT

• Related Pathways :

  Membrane Transporter/Ion Channel

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease

• Smiles :

  O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@H]1OC2=NN(C(C)C)C(C)=C2CC3=CC=C(OC)C=C3F

• Molecular Formula :

  C21H29FN2O7

• Molecular Weight :

  440.46

• References & Citations :

  [1]Malla, P., et al. (2014) . Ramping glucosuria for management of type 2 diabetes mellitus: an emerging cynosure. Medicinal research reviews, 34 (6), 1146-1167.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1

• CAS Number :

  [421592-30-5]